DEL GRAMMASTRO, MAELA
 Distribuzione geografica
Continente #
NA - Nord America 307
EU - Europa 270
AS - Asia 142
SA - Sud America 24
AF - Africa 1
OC - Oceania 1
Totale 745
Nazione #
US - Stati Uniti d'America 304
CN - Cina 54
IE - Irlanda 48
SG - Singapore 47
IT - Italia 44
UA - Ucraina 40
SE - Svezia 36
GB - Regno Unito 34
FR - Francia 27
BR - Brasile 22
TR - Turchia 21
DE - Germania 17
IN - India 15
FI - Finlandia 7
RU - Federazione Russa 6
BE - Belgio 4
CZ - Repubblica Ceca 4
CA - Canada 3
CL - Cile 2
IL - Israele 2
VN - Vietnam 2
AT - Austria 1
EG - Egitto 1
GR - Grecia 1
LB - Libano 1
LI - Liechtenstein 1
NZ - Nuova Zelanda 1
Totale 745
Città #
Chandler 62
Dublin 48
Jacksonville 48
Singapore 37
Southend 24
Ashburn 20
Beijing 19
Princeton 18
Nanjing 17
Izmir 12
Ann Arbor 11
The Dalles 10
Altamura 9
Dearborn 9
Cambridge 8
Santa Clara 6
Wilmington 6
Boardman 5
Brussels 4
Collecorvino 4
Kunming 4
Los Angeles 4
New York 4
Grevenbroich 3
Hebei 3
New Delhi 3
São Paulo 3
Tianjin 3
Washington 3
Woodbridge 3
Brno 2
Chieti 2
Council Bluffs 2
Dong Ket 2
London 2
Milan 2
Nanchang 2
Olomouc 2
Ottawa 2
San Mateo 2
Shenyang 2
Angra dos Reis 1
Barbosa 1
Bauru 1
Beirut 1
Boa Vista 1
Brooklyn 1
Cairo 1
Campinas 1
Campo Grande 1
Canzano 1
Changsha 1
Civitanova Marche 1
Concordia Sagittaria 1
Cubatão 1
Edinburgh 1
Franca 1
Frankfurt am Main 1
Ibirá 1
Itaperuna 1
Jiaxing 1
Juiz de Fora 1
Las Vegas 1
Laurel 1
Leawood 1
Londrina 1
Manchester 1
Marília 1
Munich 1
Norwalk 1
Novo Hamburgo 1
Orange 1
Osvaldo Cruz 1
Palermo 1
Paris 1
Reston 1
Rome 1
Romola 1
Santo André 1
Suffern 1
São Gabriel 1
São Gonçalo do Sapucaí 1
São Joaquim de Bicas 1
Tappahannock 1
Tauranga 1
Toronto 1
Turin 1
Zhengzhou 1
Totale 479
Nome #
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. 126
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment 122
Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications. 84
Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of NSCLC patients 78
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung. 77
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. 76
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. 72
Quantification of EGFR Mutations in Plasma of NSCLC Patients: An Early Predictor of Clinical Response to Tyrosine Kinase Inhibitor 69
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones. 67
Totale 771
Categoria #
all - tutte 3.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 0 0 0 18 2
2020/202155 10 3 11 0 3 12 0 0 5 7 0 4
2021/202252 1 2 1 12 0 2 0 1 4 9 6 14
2022/2023166 15 29 14 18 14 28 8 6 23 2 7 2
2023/202490 4 2 7 3 6 23 23 7 0 3 1 11
2024/2025141 9 25 29 5 3 12 0 5 24 8 21 0
Totale 771